Viewing Study NCT01508702


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-05-28 @ 12:27 PM
Study NCT ID: NCT01508702
Status: COMPLETED
Last Update Posted: 2016-02-12
First Post: 2012-01-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Sponsor: Ardea Biosciences, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: RDEA594-303
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators